Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2003
06/18/2003CN1425070A Rice-origin gibberellin 2 & š�-hydroxylase genes and utilization thereof
06/18/2003CN1425069A Method for purifying proteins
06/18/2003CN1425068A Fungal transcriptional activator useful in methods for producing polypeptides
06/18/2003CN1425066A Novel stra6 polypeptides
06/18/2003CN1425027A HCV non-structural polypeptide
06/18/2003CN1424403A Producing method for small molecule companion with gene engineering Escherichia coli
06/18/2003CN1424327A Preparation and use of thymic peptide alpha-1 monocloned antibody
06/18/2003CN1424325A Production of reorganized human parathyroid hormone 1-34 peptide
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase
06/17/2003US6579850 Polypeptide, novel DNA and novel antibody
06/17/2003US6579695 Phosphopantetheinyl transferases and uses thereof
06/17/2003US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor
06/17/2003US6579687 Use in diagnosing myocardial infarction and other cardiac pathologies
06/17/2003US6579683 A ligand which is a member of Ephrin family of Eph family receptor interactive protein has been shown to be expressed by arterial endothelial cells but not by venous endothelial cell, useful for distinguishing target artieris and veins
06/17/2003US6579678 Identifying evolved polynucleotides using recursive sequence recombination; recombining overlapping nucleotide sequences; screening for desired property; use in correlating different combinations of mutations with a desired result
06/17/2003US6579676 A population of recombinant cells comprising mutant cDNAs; encode a particular protein which comprises binding domains having different ligands; useful in design of new ligands and drugs
06/17/2003US6579520 IL-17 related mammalian cytokine polypeptides (IL-17E)
06/17/2003CA2222128C Surface anchoring vector and system for foreign proteins thereof
06/17/2003CA2129820C Dna sequences encoding novel growth/differentiation factors
06/17/2003CA2123315C Therapeutic agents which are antagonists or partial agonists of human interleukin 4
06/17/2003CA2072249C Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
06/12/2003WO2003048390A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003WO2003048357A1 Method of activating protein
06/12/2003WO2003048353A1 Polypeptides having protease activity and nucleic acids encoding same
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048328A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen
06/12/2003WO2003048327A2 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection
06/12/2003WO2003048321A2 Hybrid antibodies
06/12/2003WO2003048306A2 Polycistronic expression of antibodies
06/12/2003WO2003048303A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/12/2003WO2003048302A2 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
06/12/2003WO2003048301A2 Anti-hla-dr antibodies and the methods of using thereof
06/12/2003WO2003048210A1 Fusion protein having enhanced in vivo erythropoietin activity
06/12/2003WO2003048209A1 Bispecific anti-cd19 x anti-cd16 antibodies and uses thereof
06/12/2003WO2003048208A2 Expression control using variable intergenic sequences
06/12/2003WO2003048205A2 Novel proteins with il-6 inhibiting activity
06/12/2003WO2003048201A1 Antimicrobial bolisin peptides
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048189A2 Products of manufacture and processes for peptide synthesis
06/12/2003WO2003048187A2 Peptides and use thereof in therapeutic agents against hiv infection
06/12/2003WO2003047756A2 Device and method for processing biological or chemical substances or substance mixtures thereof
06/12/2003WO2003047623A1 Treatment of prostate cancer by inhibitors of ncam2
06/12/2003WO2003047621A1 CELL PROLIFERATION INHIBITOR CONTAINING ANTI-PepT ANTIBODY
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003047421A2 Methods and reagents for diagnosis and treatment of diabetes
06/12/2003WO2003047358A1 Cheese flavour ingredient and method of its production
06/12/2003WO2003047336A2 TRANSGENIC ANIMALS BEARING HUMAN Igμ LIGHT CHAIN GENES
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2002012345A3 Soluble zcytor 11 cytokine receptors
06/12/2003WO2001083701A8 Light-driven energy generation using proteorhodopsin
06/12/2003US20030110533 Acetyl-CoA carboxylase subunits
06/12/2003US20030110528 Novel ecdysone receptors and methods for their use
06/12/2003US20030110521 Anxiolytic agents; psychological disorders; insertion of genetic vector into nucleic acids, transcription
06/12/2003US20030110519 Cognition activators, sleep disorders, eating disorders, psychological disorders
06/12/2003US20030109684 Antitumor agents; transforming growth factor
06/12/2003US20030109678 Methods and means for regulation of gene expression
06/12/2003US20030109677 TIE-2 ligands, methods of making and uses thereof
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109672 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030109438 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/12/2003US20030109436 Wherein cysteine residue number 132 or 135 is replaced by another amino acid residue, preferably an alanine or serine residue and/or wherein the leucine residue at position 193 is the carboxy terminal residue. DNA sequence codes for cells
06/12/2003US20030109430 Immunoassays for human and canine brain natriuretic peptide
06/12/2003US20030109429 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
06/12/2003US20030109042 Stimulant immunology system; cell differentiation; culture product; three-dimensional support
06/12/2003US20030109024 Translation of messenger Rna; genetic engineering protein
06/12/2003US20030109022 Asp2
06/12/2003US20030109006 Isolation of lymphocytes, binding, forming culture product, cloning
06/12/2003US20030109003 Antitumor agent; transformation of expression vector; genetic engineering; process control hybrids
06/12/2003US20030109001 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies
06/12/2003US20030109000 Culture product; binding polypeptides containing activated end groups
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108997 Adjust metabolism of microorganisms; adjust gene expression of protein in Escherichia cells; reduce by-products
06/12/2003US20030108983 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030108967 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP
06/12/2003US20030108966 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/12/2003US20030108965 Using polypeptide, detection of antibody; cancer of ovaries
06/12/2003US20030108963 Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
06/12/2003US20030108953 Truncated egf receptor
06/12/2003US20030108932 Ras guanine-nucleotide-exchange factor 1 (nrg1)
06/12/2003US20030108907 Nucleic acids, proteins, and antibodies
06/12/2003US20030108904 Novel scavenger receptors
06/12/2003US20030108896 Method for detection of melanoma
06/12/2003US20030108889 Mutations; cloning; immunoglobulins; genetic engineering
06/12/2003US20030108885 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
06/12/2003US20030108860 Growing high density culture (serum-free) of adherent cells bound to microcarrier (dextran), infecting cells, then incubating
06/12/2003US20030108858 Methods for the simultaneous detection of HCV antigens and HCV antibodies
06/12/2003US20030108572 Antigenic preparations and the isolation of such preparations
06/12/2003US20030108559 Induction immunology response; cardiovascular disorders, anticholesterol agents
06/12/2003US20030108557 Biosynthesis; contacting plant cell with genetic engineered nucleic acid virus; gene expression of fusion protein; splitting using cyanogen bromide
06/12/2003US20030108550 Anti-procalcitonin antibodies and the preparation and use thereof
06/12/2003US20030108545 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
06/12/2003US20030108540 Inducing apoptosis in tissues; binding antibodies
06/12/2003US20030108538 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies
06/12/2003US20030108518 TRX1 antibody and uses therefor
06/12/2003US20030106798 Factor VIII separation
06/12/2003CA2847885A1 Transgenic animals bearing human ig.lambda. light chain genes
06/12/2003CA2811997A1 Antibodies against monocyte chemotactic proteins
06/12/2003CA2469671A1 A process for the preparation of a non-toxic anthrax vaccine
06/12/2003CA2469477A1 Phenotypic screen of chimeric proteins
1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 1125